• Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations 

      König, Marton; Lorentzen, Åslaug Rudjord; Torgauten, Hilde Marie; Tran, The Trung; Schikora-Rustad, Stine; Vaage, Eline Benno; Mygland, Åse Daasvand; Wergeland, Stig; Aarseth, Jan Harald; Aaberge, Ingeborg Sundsvalen; Torkildsen, Øivind; Holmøy, Trygve; Berge, Tone; Myhr, Kjell-Morten; Harbo, Hanne-Cathrin Flinstad; Andersen, Jan Terje; Munthe, Ludvig Andre; Søraas, Arne Vasli; Celius, Elisabeth Gulowsen; Vaage, John T.; Lund-Johansen, Fridtjof; Nygaard, Gro Owren (Journal of Neurology, Neurosurgery and Psychiatry;, Peer reviewed; Journal article, 2021-10-20)
      Introduction: The effect of disease-modifying therapies (DMT) on vaccine responses is largely unknown. Understanding the development of protective immunity is of paramount importance to fight the COVID-19 pandemic. Objective: ...
    • Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: The relevance of time since last rituximab infusion and first experience from sporadic revaccinations 

      König, Marton; Lorentzen, Åslaug Rudjord; Torgauten, Hilde Marie; Tran, Trung; Schikora-Rustad, Stine; Vaage, Eline Benno; Mygland, Åse Daasvand; Wergeland, Stig; Aarseth, Jan Harald; Aaberge, Ingeborg Sundsvalen; Torkildsen, Øivind; Holmøy, Trygve; Berge, Tone; Myhr, Kjell-Morten; Harbo, Hanne-Cathrin Flinstad; Andersen, Jan Terje; Munthe, Ludvig Andre; Søraas, Arne Vasli; Celius, Elisabeth Gulowsen; Vaage, John T.; Lund-Johansen, Fridtjof; Nygaard, Gro Owren (Peer reviewed; Journal article, 2021)
      Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is largely unknown. Understanding the development of protective immunity is of paramount importance to fight the COVID-19 pandemic. Objective ...
    • Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis 

      Brune-Ingebretsen, Synne; Høgestøl, Einar August; de Rosbo, Nicole Kerlero; Berg-Hansen, Pål; Brunborg, Cathrine; Blennow, Kaj; Zetterberg, Henrik; Paul, Friedemann; Uccelli, Antonio; Villoslada, Pablo; Harbo, Hanne-Cathrin Flinstad; Berge, Tone (Peer reviewed; Journal article, 2023)
      Changes is lymphocyte subpopulations in peripheral blood have been proposed as biomarkers for evaluation of disease activity in multiple sclerosis (MS). Serum neurofilament light chain (sNfL) is a biomarker reflecting ...
    • Predicting disease severity in multiple sclerosis using multimodal data and machine learning 

      Andorra, Magi; Freire, Ana; Zubizarreta, Irati; de Rosbo, Nicole Kerlero; Bos, Steffan Daniel; Rinas, Melanie; Høgestøl, Einar August; de Rodez Benavent, Sigrid Aune; Berge, Tone; Brune, Synne; Ivaldi, Federico; Cellerino, Maria; Pardini, Matteo; Vila, Gemma; Pulido-Valdeolivas, Irene; Martinez-Lapiscina, Elena H.; Llufriu, Sara; Saiz, Albert; Blanco, Yolanda; Martinez-Heras, Eloy; Solana, Elisabeth; Bäcker-Koduah, Priscilla; Behrens, Janina; Kuchling, Joseph; Asseyer, Susanna; Scheel, Michael; Chien, Claudia; Zimmermann, Hanna; Motamedi, Seyedamirhosein; Kauer-Bonin, Josef; Brandt, Alex; Saez-Rodriguez, Julio; Alexopoulos, Leonidas G.; Paul, Friedemann; Harbo, Hanne-Cathrin Flinstad; Shams, Hengameh; Oksenberg, Jorge; Uccelli, Antonio; Baeza-Yates, Ricardo; Villoslada, Pablo (Peer reviewed; Journal article, 2023)
      Background Multiple sclerosis patients would benefit from machine learning algorithms that integrates clinical, imaging and multimodal biomarkers to define the risk of disease activity. Methods We have analysed a prospective ...